2-Fluoro Atorvastatin (Sodium Salt)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1346598-86-42-Fluoro Atorvastatin (Sodium Salt)

● In Stock

Catalogue No.:VE009131
CAS No.:1346598-86-4
Mol. Formula:C33H34FN2NaO5
Mol. Weight:580.62 g/mol

Additional information on CAS 1346598-86-4

Parent drug

Atorvastatin

IUPAC Name

sodium (3R, 5R)-7-(2-(2-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3, 5-dihydroxyheptanoate

Synonyms

N/A

Smiles

CC(C)c4c(C(=O)Nc1ccccc1)c(c2ccccc2)c(c3ccccc3F)n4CC[C@@H](O)C[C@@H](O)CC(=O)O[Na+]

Description

It is an impurity present in Atorvastatin, Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA, also reduces Very-Low-Density Lipoprotein-Cholesterol, serum triglycerides, and Intermediate Density Lipoproteins, as well as the number of apolipoprotein B containing particles, but increases High-Density Lipoprotein Cholesterol, which is used to reduce the risk of cardiovascular disease including myocardial infarction and stroke.

References

‌McIver, L. A., & Siddique, M. S. (2022, May 15). Atorvastatin. Retrieved August 19, 2022, from Nih.gov website: https://www.ncbi.nlm.nih.gov/books/NBK430779/

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url